Detalhe da pesquisa
1.
Prediabetes is associated with proteinuria development but not with glomerular filtration rate decline: A longitudinal observational study.
Diabet Med
; 38(8): e14607, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031914
2.
Healthy lifestyle reduces incidence of trace/positive proteinuria and rapid kidney function decline after 2 years: from the Japan Ningen Dock study.
Nephrol Dial Transplant
; 36(6): 1039-1048, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33247759
3.
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review.
Cerebrovasc Dis
; 50(3): 245-261, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756459
4.
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.
Lancet
; 383(9913): 245-54, 2014 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449944
5.
Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
Cerebrovasc Dis
; 37(4): 296-303, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24820203
6.
Comparison of the European and Japanese guidelines for the management of ischemic stroke.
Cerebrovasc Dis
; 35(5): 402-18, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23712178
7.
Comparison of the European and Japanese guidelines for the acute management of intracerebral hemorrhage.
Cerebrovasc Dis
; 35(5): 419-29, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23712243
8.
Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolic cerebral infarction.
J Stroke Cerebrovasc Dis
; 22(5): 668-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22622391
9.
Safety of the novel protease-activated receptor-1 antagonist vorapaxar in Japanese patients with a history of ischemic stroke.
J Stroke Cerebrovasc Dis
; 21(4): 318-24, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947374
10.
Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. -The ARISTOTLE-J study-.
Circ J
; 75(8): 1852-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670542
11.
Platelet aggregates detected by a conventional hematology analyzer method is a risk factor for stroke or a predictive factor in patients with chronic-stage cerebral infarction.
J Stroke Cerebrovasc Dis
; 20(4): 275-81, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20634095
12.
Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).
Stroke
; 41(9): 1984-9, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20651262
13.
Stroke: working toward a prioritized world agenda.
Stroke
; 41(6): 1084-99, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20498453
14.
Factors affecting health-related quality of life assessed with the SF-36v2 health survey in outpatients with chronic-stage ischemic stroke in Japan--cross-sectional analysis of the OASIS study.
Cerebrovasc Dis
; 29(4): 361-71, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20145390
15.
Stroke: working toward a prioritized world agenda.
Cerebrovasc Dis
; 30(2): 127-47, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516682
16.
Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS.
Stroke
; 40(8): 2862-5, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19520981
17.
Postpublication external review of the Japanese guidelines for the management of stroke 2004.
Stroke
; 40(4): 1439-43, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19228839
18.
Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Cerebrovasc Dis
; 27(5): 485-92, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19321945
19.
Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials.
J Stroke Cerebrovasc Dis
; 18(6): 482-90, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19900653
20.
Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
Stroke
; 39(6): 1827-33, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18388340